TundeAkinkuolieMD

PubMed

• Are there sex differences in acute coronary syndrome presentation?: a guide through the maze.
  Akinkuolie AO, Mora S> ;JAMA internal medicine.
• Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
  Dugani SB, Akinkuolie AO, Paynter N, Glynn RJ, Ridker PM, Mora S> ;JAMA cardiology.
• Markers of Inflammation and Incident Breast Cancer Risk in the Women's Health Study.
  Tobias DK, Akinkuolie AO, Chandler PD, Lawler PR, Manson JE, Buring JE, Ridker PM, Wang L, Lee IM, Mora S> ;American journal of epidemiology.
• GlycA, a novel inflammatory marker, is associated with subclinical coronary disease.
  Tibuakuu M, Fashanu OE, Zhao D, Otvos JD, Brown TT, Haberlen SA, Guallar E, Budoff MJ, Palella FJ, Martinson JJ, Akinkuolie AO, Mora S, Post WS, Michos ED> ;AIDS (London, England).
• {"__content__"=>"Group IIA Secretory Phospholipase A, Vascular Inflammation, and Incident Cardiovascular Disease.", "sub"=>{"__content__"=>"2"}}
  Akinkuolie AO, Lawler PR, Chu AY, Caulfield M, Mu J, Ding B, Nyberg F, Glynn RJ, Ridker PM, Hurt-Camejo E, Chasman DI, Mora S> ;Arteriosclerosis, thrombosis, and vascular biology.
• Habitual Fish Consumption, n-3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women.
  Amigó N, Akinkuolie AO, Chiuve SE, Correig X, Cook NR, Mora S> ;Journal of the American Heart Association. 2020-02-27
• Associations of ideal cardiovascular health with GlycA, a novel inflammatory marker: The Multi-Ethnic Study of Atherosclerosis.
  Benson EA, Tibuakuu M, Zhao D, Akinkuolie AO, Otvos JD, Duprez DA, Jacobs DR, Mora S, Michos ED> ;Clinical cardiology. 2018-11-19
• Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins.
  Lawler PR, Akinkuolie AO, Harada P, Glynn RJ, Chasman DI, Ridker PM, Mora S> ;Journal of the American Heart Association. 2017-12-09
• Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
  Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, Padmanabhan L, Glynn RJ, Ridker PM, Chasman DI, Mora S> ;Journal of the American Heart Association. 2017-07-21
• Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study.
  Harada PHN, Demler OV, Dugani SB, Akinkuolie AO, Moorthy MV, Ridker PM, Cook NR, Pradhan AD, Mora S> ;Journal of clinical lipidology. 2017-06-21
• Effects of statins on the immunoglobulin G glycome.
  Keser T, Vučković F, Barrios C, Zierer J, Wahl A, Akinkuolie AO, Štambuk J, Nakić N, Pavić T, Periša J, Mora S, Gieger C, Menni C, Spector TD, Gornik O, Lauc G> ;Biochimica et biophysica acta. General subjects. 2017-03-02
• Associations of Diabetes and Obesity with Risk of Abdominal Aortic Aneurysm in Men.
  Wang L, Djousse L, Song Y, Akinkuolie AO, Matsumoto C, Manson JE, Gaziano JM, Sesso HD> ;Journal of obesity. 2017-02-23
• Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women.
  Lawler PR, Akinkuolie AO, Ridker PM, Sniderman AD, Buring JE, Glynn RJ, Chasman DI, Mora S> ;Clinical chemistry. 2017-02-07
• Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality.
  Chandler PD, Akinkuolie AO, Tobias DK, Lawler PR, Li C, Moorthy MV, Wang L, Duprez DA, Jacobs DR, Glynn RJ, Otvos J, Connelly MA, Post WS, Ridker PM, Manson JE, Buring...> ;PloS one. 2016-11-30
• Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial.
  Akinkuolie AO, Glynn RJ, Padmanabhan L, Ridker PM, Mora S> ;Journal of the American Heart Association. 2016-07-13
• Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk.
  Lawler PR, Akinkuolie AO, Chandler PD, Moorthy MV, Vandenburgh MJ, Schaumberg DA, Lee IM, Glynn RJ, Ridker PM, Buring JE, Mora S> ;Circulation research. 2016-03-07
• Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State.
  White KT, Moorthy MV, Akinkuolie AO, Demler O, Ridker PM, Cook NR, Mora S> ;Clinical chemistry. 2015-06-12
• Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.
  Akinkuolie AO, Pradhan AD, Buring JE, Ridker PM, Mora S> ;Arteriosclerosis, thrombosis, and vascular biology. 2015-04-23
• A novel protein glycan biomarker and future cardiovascular disease events.
  Akinkuolie AO, Buring JE, Ridker PM, Mora S> ;Journal of the American Heart Association. 2014-09-23
• Paradoxical association of lipoprotein measures with incident atrial fibrillation.
  Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM> ;Circulation. Arrhythmia and electrophysiology. 2014-05-25
• High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.
  Akinkuolie AO, Paynter NP, Padmanabhan L, Mora S> ;Circulation. Cardiovascular quality and outcomes. 2013-11-18
• Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis.
  Djoussé L, Akinkuolie AO, Wu JH, Ding EL, Gaziano JM> ;Clinical nutrition (Edinburgh, Scotland). 2012-06-06
• Height and risk of heart failure in the Physicians' Health Study.
  Akinkuolie AO, Aleardi M, Ashaye AO, Gaziano JM, Djoussé L> ;The American journal of cardiology. 2012-01-03
• Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.
  Akinkuolie AO, Ngwa JS, Meigs JB, Djoussé L> ;Clinical nutrition (Edinburgh, Scotland). 2011-09-29
• Join now to see all